Tango Therapeutics (TNGX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$19.2 million.
- Tango Therapeutics' Other Gross PP&E Adjustments rose 2042.16% to -$19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year increase of 2042.16%. This contributed to the annual value of -$23.0 million for FY2024, which is 1666.0% up from last year.
- Tango Therapeutics' Other Gross PP&E Adjustments amounted to -$19.2 million in Q3 2025, which was up 2042.16% from -$20.2 million recorded in Q2 2025.
- Tango Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $11.0 million during Q2 2022, with a 5-year trough of -$33.3 million in Q3 2022.
- Over the past 5 years, Tango Therapeutics' median Other Gross PP&E Adjustments value was -$24.1 million (recorded in 2024), while the average stood at -$18.7 million.
- As far as peak fluctuations go, Tango Therapeutics' Other Gross PP&E Adjustments skyrocketed by 39941.78% in 2021, and later plummeted by 1149280.82% in 2022.
- Over the past 5 years, Tango Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $6.1 million in 2021, then plummeted by 633.49% to -$32.3 million in 2022, then increased by 14.61% to -$27.6 million in 2023, then rose by 16.66% to -$23.0 million in 2024, then grew by 16.67% to -$19.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$19.2 million in Q3 2025, compared to -$20.2 million in Q2 2025 and -$23.2 million in Q1 2025.